PCDH19-clustering epilepsy, pathophysiology and clinical significance

Safoura Kowkabi1, Majid Yavarian2, Reza Kaboodkhani3

  • 1Child Neurology Division and Children's Epilepsy Monitoring Unit, Children's Medical Centre, Tehran University of Medical Sciences, Tehran, Iran; Shiraz University of Medical Sciences, Shiraz, Iran.

PubMed

Insights

PCDH19 clustering epilepsy (PCDH19-CE) affects females due to PCDH19 gene variants, presenting unusual inheritance. Beyond cellular interference, other mechanisms like hormonal imbalances and BBB dysfunction contribute to this rare epilepsy.

Area of Science:

  • Neuroscience
  • Genetics
  • Epilepsy Research

Background:

  • PCDH19 clustering epilepsy (PCDH19-CE) is an X-linked disorder causing seizures, intellectual disability, and behavioral issues.
  • Pathogenic PCDH19 variants typically affect heterozygous females, with an unusual inheritance pattern where males are often spared.
  • The cellular interference hypothesis has been a primary explanation for PCDH19-CE pathogenesis.

Purpose of the Study:

  • To review the pathophysiology of PCDH19-CE.
  • To explore potential pathogenic mechanisms beyond cellular interference.
  • To inform therapeutic decisions by understanding diverse disease pathways.

Main Methods:

  • Comprehensive literature review on PCDH19-CE.
  • Analysis of genetic and molecular mechanisms.
  • Synthesis of findings related to neurodevelopmental and functional deficits.

Main Results:

  • PCDH19 variants cause epilepsy in heterozygous females, with males usually unaffected due to uniform gene expression.
  • Additional pathogenic mechanisms identified include asymmetric cell division, heterochrony, allopregnanolone deficiency, altered steroid gene expression, reduced GABAA function, and blood-brain barrier dysfunction.
  • These diverse mechanisms highlight the complexity of PCDH19-CE.

Conclusions:

  • PCDH19-CE pathogenesis involves multiple factors beyond the initial cellular interference hypothesis.
  • Understanding these varied mechanisms is crucial for tailoring patient-specific therapeutic strategies.
  • Further research into these pathways may reveal novel treatment targets for PCDH19-CE.

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
610
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
340
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
389